Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
7495 New Horizon Way, Frederick, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
SELECTA BIOSCIENCES INC (to 11/13/2023)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 365 % -26.3%
Debt-to-equity -272 % -393%
Return On Equity 149 %
Return On Assets -68.3 % -168%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.4M shares -83.6%
Common Stock, Shares, Outstanding 23.9M shares -84.6%
Entity Public Float 129M USD -14%
Common Stock, Value, Issued 2K USD -86.7%
Weighted Average Number of Shares Outstanding, Basic 21.5M shares +316%
Weighted Average Number of Shares Outstanding, Diluted 21.5M shares +316%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 387K USD -94.1%
Revenue from Contract with Customer, Excluding Assessed Tax 47.4M USD +37.2%
Research and Development Expense 56.2M USD -17.8%
General and Administrative Expense 45.2M USD +82.7%
Operating Income (Loss) -53.5M USD +8.68%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9M USD -9.59%
Income Tax Expense (Benefit) -321K USD -102%
Net Income (Loss) Attributable to Parent -245M USD -577%
Earnings Per Share, Basic -4.5 USD/shares +45.2%
Earnings Per Share, Diluted -4.54 USD/shares +44.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 219M USD +175%
Accounts Receivable, after Allowance for Credit Loss, Current 4.83M USD -1.41%
Assets, Current 229M USD +155%
Property, Plant and Equipment, Net 10.2M USD +322%
Operating Lease, Right-of-Use Asset 13.5M USD +30.8%
Goodwill 48.2M USD
Assets 455M USD +329%
Accounts Payable, Current 517K USD +37.9%
Employee-related Liabilities, Current 1.78M USD -62.8%
Accrued Liabilities, Current 9.36M USD -31.3%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 21.4M USD +7.35%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 15.9M USD
Operating Lease, Liability, Noncurrent 11.9M USD +36.7%
Liabilities 455M USD +895%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.61M USD +0.22%
Retained Earnings (Accumulated Deficit) -682M USD -56%
Stockholders' Equity Attributable to Parent 752K USD -98.8%
Liabilities and Equity 455M USD +329%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.9M USD -81.6%
Net Cash Provided by (Used in) Financing Activities 43M USD +28780%
Net Cash Provided by (Used in) Investing Activities -602K USD -102%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 23.9M shares -84.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 221M USD +173%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 124M USD -2.76%
Deferred Tax Assets, Gross 152M USD +16.3%
Operating Lease, Liability 14.7M USD +39.8%
Depreciation 900K USD +28.6%
Payments to Acquire Property, Plant, and Equipment 602K USD +363%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -245M USD -575%
Lessee, Operating Lease, Liability, to be Paid 19.5M USD +49.3%
Property, Plant and Equipment, Gross 16.5M USD +103%
Operating Lease, Liability, Current 2.77M USD +55%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.54M USD +61%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.42M USD +61.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +20.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.87M USD +88%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.35M USD +49.7%
Deferred Tax Assets, Operating Loss Carryforwards 29.8M USD +75.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9.38M shares -6.18%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.31M USD -22.6%
Operating Lease, Payments 761K USD +16.5%
Additional Paid in Capital 687M USD +36.9%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 22.1M USD +108%
Interest Expense 2.03M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%